These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 15630843)
1. Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy. Lee LW; McBain CA; Swindell R; Wylie JP; Cowan RA; Logue JP Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):517-22. PubMed ID: 15630843 [TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Do T; Parker RG; Do C; Tran L; Do L; Dolkar D Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297 [TBL] [Abstract][Full Text] [Related]
3. Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience. Murgic J; Jaksic B; Prpic M; Kust D; Bahl A; Budanec M; Prgomet Secan A; Franco P; Kruljac I; Spajic B; Babic N; Kruslin B; Zovak M; Zubizarreta E; Rosenblatt E; Fröbe A Radiat Oncol; 2021 May; 16(1):88. PubMed ID: 33980277 [TBL] [Abstract][Full Text] [Related]
4. Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Wilder RB; Hsiang JY; Ji M; Earle JD; de Vere White R Am J Clin Oncol; 2000 Apr; 23(2):176-80. PubMed ID: 10776980 [TBL] [Abstract][Full Text] [Related]
5. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
6. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
7. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
8. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. Katz MS; Zelefsky MJ; Venkatraman ES; Fuks Z; Hummer A; Leibel SA J Clin Oncol; 2003 Feb; 21(3):483-9. PubMed ID: 12560439 [TBL] [Abstract][Full Text] [Related]
9. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439 [TBL] [Abstract][Full Text] [Related]
10. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. Stephenson AJ; Shariat SF; Zelefsky MJ; Kattan MW; Butler EB; Teh BS; Klein EA; Kupelian PA; Roehrborn CG; Pistenmaa DA; Pacholke HD; Liauw SL; Katz MS; Leibel SA; Scardino PT; Slawin KM JAMA; 2004 Mar; 291(11):1325-32. PubMed ID: 15026399 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Kneebone A; Fraser-Browne C; Duchesne GM; Fisher R; Frydenberg M; Herschtal A; Williams SG; Brown C; Delprado W; Haworth A; Joseph DJ; Martin JM; Matthews JHL; Millar JL; Sidhom M; Spry N; Tang CI; Turner S; Wiltshire KL; Woo HH; Davis ID; Lim TS; Pearse M Lancet Oncol; 2020 Oct; 21(10):1331-1340. PubMed ID: 33002437 [TBL] [Abstract][Full Text] [Related]
12. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level. Tiguert R; Rigaud J; Lacombe L; Laverdière J; Fradet Y J Urol; 2003 Aug; 170(2 Pt 1):447-50. PubMed ID: 12853796 [TBL] [Abstract][Full Text] [Related]
14. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. Chawla AK; Thakral HK; Zietman AL; Shipley WU Urology; 2002 May; 59(5):726-31. PubMed ID: 11992848 [TBL] [Abstract][Full Text] [Related]
15. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039 [TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716 [TBL] [Abstract][Full Text] [Related]
17. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Song DY; Thompson TL; Ramakrishnan V; Harrison R; Bhavsar N; Onaodowan O; DeWeese TL Urology; 2002 Aug; 60(2):281-7. PubMed ID: 12137827 [TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Kupelian P; Katcher J; Levin H; Zippe C; Klein E Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737 [TBL] [Abstract][Full Text] [Related]
19. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions]. Quero L; Mongiat-Artus P; Ravery V; Hennequin V; Maylin C; Desgrandchamps F; Hennequin C Cancer Radiother; 2009 Jul; 13(4):267-75. PubMed ID: 19446487 [TBL] [Abstract][Full Text] [Related]
20. Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates. Pazona JF; Han M; Hawkins SA; Roehl KA; Catalona WJ J Urol; 2005 Oct; 174(4 Pt 1):1282-6. PubMed ID: 16145393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]